Covered recipient · General Payments record
JANET L EICHHOLZ
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$8,288.83
- Reported across 228 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $417.78 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ATRICURE, INC. | $234.93 | 6 |
| PFIZER INC. | $51.84 | 3 |
| Philips Electronics North America Corporation | $50.81 | 3 |
| SCPHARMACEUTICALS INC. | $18.52 | 1 |
| Acerta Pharma LLC | $17.60 | 1 |
| Amgen Inc. | $15.10 | 1 |
| Novo Nordisk AS | $14.75 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.10 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111568465 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.60 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105795680 | CMS |
| ATRICURE, INC. | $48.58 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132855063 | CMS |
| ATRICURE, INC. | $47.24 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132846045 | CMS |
| ATRICURE, INC. | $49.69 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132850501 | CMS |
| ATRICURE, INC. | $46.57 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132850174 | CMS |
| ATRICURE, INC. | $20.41 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132874904 | CMS |
| ATRICURE, INC. | $22.44 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132874902 | CMS |
| Novartis Pharmaceuticals Corporation | $14.23 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086882751 | CMS |
| Novo Nordisk Inc | $14.75 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096764715 | CMS |
| PFIZER INC. | $17.57 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131533851 | CMS |
| PFIZER INC. | $16.58 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131545965 | CMS |
| PFIZER INC. | $17.69 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131573491 | CMS |
| Philips North America LLC | $14.94 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146858624 | CMS |
| Philips North America LLC | $14.17 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146858626 | CMS |
| Philips North America LLC | $21.70 | 08/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146858628 | CMS |
| SCPHARMACEUTICALS INC. | $18.52 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132276925 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.